Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0001395064-21-000058

10% owner sold 33,992 shares at an average $37.00 ($1,257,849)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2021-05-03 Sale −3,157 $37.60 $118,703 1,080,843 D: show line 1 in the form
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2021-05-03 Sale −11,272 $38.45 $433,408 1,069,571 D: show line 2 in the form
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2021-05-03 Sale −203 $39.06 $7,929 1,069,368 D: show line 3 in the form
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2021-05-04 Sale −11,070 $35.50 $392,985 1,058,298 D: show line 4 in the form
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2021-05-04 Sale −4,690 $36.21 $169,825 1,053,608 D: show line 5 in the form
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2021-05-04 Sale −3,500 $37.47 $131,145 1,050,108 D: show line 6 in the form
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2021-05-04 Sale −100 $38.53 $3,853 1,050,008 D: show line 7 in the form
Open-market sales · 33,992 sh · avg $37.00 · $1,257,849
Loading xslF345X03/wf-form4_162021757083358.xml…